Wednesday, March 08, 2017 3:41:39 PM
Recent ACHV News
- Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study • GlobeNewswire Inc. • 03/04/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 09:09:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 09:08:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 09:07:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 09:06:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 09:05:03 PM
- Achieve Life Sciences Announced Granting of New Hire Inducement Awards • GlobeNewswire Inc. • 01/30/2026 09:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/30/2026 05:15:28 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/23/2026 09:04:43 PM
- Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer • GlobeNewswire Inc. • 01/12/2026 01:47:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2026 01:10:03 PM
- Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week • PR Newswire (US) • 12/17/2025 09:11:00 PM
- Achieve Life Sciences Announced Granting of New Hire Inducement Awards • GlobeNewswire Inc. • 12/08/2025 09:10:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 12:15:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2025 12:10:25 PM
- Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program • GlobeNewswire Inc. • 11/06/2025 12:00:00 PM
- Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation • GlobeNewswire Inc. • 11/03/2025 01:30:00 PM
- Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025 • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/21/2025 08:57:38 PM
- Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer • GlobeNewswire Inc. • 10/20/2025 12:30:00 PM
- Achieve Life Sciences shares surge on FDA priority voucher news • IH Market News • 10/17/2025 01:54:32 PM
- Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation • GlobeNewswire Inc. • 10/17/2025 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2025 08:51:49 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
